Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05805384 · ClinicalTrials.gov registry record · NA
Evaluating a Noise Reduction Algorithm With Cochlear Implant Users
A NA study of Hearing Impairment, sponsored by NYU Langone Health.
- Recruiting
- Registry status
- NA
- Development phase
- 60
- Enrollment target
- 1
- Study location
NCT05805384 is a NA study of Hearing Impairment that is actively recruiting participants, run by NYU Langone Health. The registered enrollment target is 60 participants. The trial reports 1 study location across 1 state.
The verdict
NCT05805384, a NA study of Hearing Impairment, is actively recruiting participants, sponsored by NYU Langone Health.
- RECRUITING
- Registry status
- NA
- Development phase
- 60 participants
- Enrollment target
- 1
- Study location
Study Summary
In this study, a noise reduction algorithm will be implemented in various listening situations to evaluate its effectiveness in improving speech understanding for cochlear implant users ages 12 and older.
Conditions Studied
Interventions
- DEVICE SEDA
Study Locations (1)
New York
- Tisch Hospital - New York
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 60 participants |
| Start Date | 2023-03-01 |
| Est. Completion | 2027-03-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05805384
The ClinicalTrials.gov registry entry for NCT05805384 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 60 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is NYU Langone Health, which has 1,164 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Hearing Impairment appearing as the primary indexed condition, and to 1 intervention - of which SEDA is the first listed.
NCT05805384 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.
Frequently Asked Questions
What is clinical trial NCT05805384 about?
NCT05805384 is a clinical study titled "Evaluating a Noise Reduction Algorithm With Cochlear Implant Users". In this study, a noise reduction algorithm will be implemented in various listening situations to evaluate its effectiveness in improving speech understanding for cochlear implant users ages 12 and older.
What is the current status of trial NCT05805384?
This trial is currently recruiting. It is a NA study. The enrollment target is 60 participants. The study started on 2023-03-01. Estimated completion is 2027-03-01.
What conditions does trial NCT05805384 study?
This clinical trial studies the following conditions: Hearing Impairment.
What interventions are being tested in trial NCT05805384?
The interventions under investigation include: SEDA (DEVICE).
Who is sponsoring clinical trial NCT05805384?
This trial is sponsored by NYU Langone Health, which has 1,164 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05805384 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Hearing Impairment
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.